Navigation Links
Senesco Technologies Reports First Quarter Fiscal 2010 Financial Results
Date:11/17/2009

trial for multiple myeloma
  • Richard Dondero, Vice President of Research & Development at Senesco, delivered the Company's corporate presentation at the 11th Annual Rodman & Renshaw Healthcare Conference
  • "SNS-01 continues to demonstrate potential as a possible treatment for multiple myeloma, most recently being the subject of a poster presentation at one of the most important oncology conferences of the year, the annual AACR-NCI-EORTC Conference," said Jack Van Hulst, President and Chief Executive Officer of Senesco.

    The Company did not record any revenue for the three month period ended September 30, 2009. Total revenues of $200,000 for the three month period ended September 30, 2008 consisted of a milestone payment in connection with an agricultural license agreement.

    Research and development expenses during the three month period ended September 30, 2009 were $575,291, compared with $504,386 during the three month period ended September 30, 2008, an increase of 14.1%. This increase was primarily a result of an $89,000 loss on the extinguishment of debt in connection with the issuance of common stock and warrants to Cato Holding Company in exchange for debt that was owed by Senesco to Cato Research Ltd. in the amount of $175,000, which was slightly offset by decrease in the cost of the research performed at the University of Waterloo as a result of the stronger U.S. dollar against the Canadian dollar.

    General and administrative expenses were $494,955 for the three month period ended September 30, 2009, compared with $529,865 during the three month period ended September 30, 2008, a decrease of 6.6%. This decrease was due primarily to a $34,000 decrease in stock based compensation, and a $20,000 decrease in professional fees, which were a result of a decrease in legal and accounting fees related to the review of our securities filings. These decreases were slightly offset by a $15,000 i
    '/>"/>

    SOURCE Senesco Technologies, Inc.
    Copyright©2009 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7

    Related medicine technology :

    1. Senesco Presents Pre-Clinical Stability and Biological Activity Data on SNS-01 at the 2009 AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference
    2. Senesco Announces H1N1 Influenza Survival Test Results in Mice
    3. Senesco Chooses VGXI to Produce Factor 5A Plasmid
    4. Senesco Expands on Recently Announced Preclinical Pancreatic Islet Data
    5. Senescos Preclinical Pancreatic Islet Data to be Presented at Upcoming Conferences
    6. Senesco Technologies Initiates Preclinical Studies for Cancer Target
    7. EF Johnson Technologies Announces Third Quarter Results
    8. Ionian Technologies, Inc. Signs Molecular Diagnostic Manufacturing Agreement With Roche Diagnostics
    9. Celling Technologies Signs Exclusive Agreement to Research and Develop Adipose Tissue Stem Cell Technology in Regenerative Medicine Institutes
    10. ARmark Authentication Technologies, LLC and Colorcon, Inc. Announce Alliance
    11. Althea Technologies Adds Formulation Development to Its Integrated Offering of Contract Services
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:1/15/2014)... YORK , Jan. 15, 2014 ... report is available in its catalogue: ... India Drug Forecast and Market Analysis to ... PharmaPoint: Atopic Dermatitis - India Drug ...
    (Date:1/15/2014)... 15, 2014  Zafgen, Inc., a leading biopharmaceutical company ... obese patients, today announced initial results from its ... of methionine aminopeptidase 2 (MetAP2), in patients with ... obesity.  These results showed improvements in body weight, ...
    (Date:1/14/2014)... , Jan. 14, 2014 InformEx, North America,s ... of high-value chemistry, will hold the 30 th edition ... Convention Center from January 21-24. (Logo: ... from top pharmaceutical, fine chemical and specialty chemical companies will ...
    Breaking Medicine Technology:PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 2PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 4PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 5Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 2Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 3Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 4Media Advisory: InformEx 2014 Events & Speaker Lineup for 30th Edition Conference in Miami Beach 2
    (Date:4/23/2014)... Parents and physicians concerned about an increase in adolescents, ... breathe a sigh of relief. According to a new ... worth of data from states with and without medical ... increased use among adolescents. The study is published online ... Adolescent Health . , "Any time a state ...
    (Date:4/23/2014)... of endogenous neural precursor cells cannot alone compensate ... the perspective of neural plasticity, Dr. Yun Xiang ... observed the effects of functional electrical stimulation treatment ... of basic fibroblast growth factor and epidermal growth ... side. The researchers found that functional electrical stimulation ...
    (Date:4/22/2014)... A recently FDA-approved device has been shown to reduce ... as 50 percent. When coupled with an innovative electrode ... device facilitated the complete elimination of seizures in nearly ... decade-long clinical trials. , That,s good news for a ... U.S. living with epilepsy whose seizures can,t be controlled ...
    (Date:4/22/2014)... are small cell lung cancers (SCLC), which grow ... researchers at Virginia Commonwealth University Massey Cancer Center ... to this resistance that may lead to improved ... B-cell lymphoma 2 (Bcl-2) family proteins, which are ... function, this family of proteins can trigger a ...
    (Date:4/22/2014)... scientists have found a way to block abnormal cholesterol ... atherosclerosis, the main cause of heart attacks and strokes ... condition develops when fat builds inside blood vessels over ... reducing their ability to feed oxygen-rich blood to the ... of experiments, described April 7 in the journal ...
    Breaking Medicine News(10 mins):Health News:RI Hospital physician: Legalizing medical marijuana doesn't increase use among adolescents 2Health News:Newly approved brain stimulator offers hope for individuals with uncontrolled epilepsy 2Health News:Scientists pinpoint protein that could improve small cell lung cancer therapies 2Health News:Scientists alter fat metabolism in animals to prevent most common type of heart disease 2Health News:Scientists alter fat metabolism in animals to prevent most common type of heart disease 3Health News:Scientists alter fat metabolism in animals to prevent most common type of heart disease 4
    ... ST. LOUIS, Aug. 18 Reliv International, Inc. (Nasdaq: ... and business tools for its independent distributors here at its 21st annual ... Highlights of the conference included: , , The ... exclusive "r( )collection" of personal care products. (See www.re ...
    ... Hospitals, Physicians Work Together to Cut Costs, Improve ... 18 Twelve New Jersey hospitals and their participating physicians are ... that will evaluate gainsharing as an innovative new incentive method that ... , "Rising healthcare costs are a growing burden ...
    ... , SUNNYVALE, Calif., Aug. 18 ... systems including the Expresso Fitness Virtual Reality Bike, announced today ... excess of $6 million from Sierra Ventures, Physic Ventures, and ... company to enhance and accelerate new features and functionality to ...
    ... , OKLAHOMA CITY, Aug. 18 Almost everyone ... ar a cts at some point. As more Americans ... cataract basics: risks and symptoms, tips that may delay onset, and how to ... , , August is Cataract Awareness Month, and the Oklahoma ...
    ... AUSTIN, Texas, Aug. 18 Almost everyone who lives a ... some point. As more Americans live into their 70s and beyond, we ... that may delay onset, and how to decide when it is time ... August is Cataract Awareness Month, and the Texas Ophthalmological Association (TOA) ...
    ... of polyphenols , TUESDAY, Aug. 18 (HealthDay News) -- ... is a great source of natural antioxidants, new research ... the University of Scranton, in Pennsylvania, and his team ... many common, grain-based snacks contain substantial amounts of polyphenols, ...
    Cached Medicine News:Health News:Reliv International Launches New Products and Business Tools at 21st International Conference 2Health News:Reliv International Launches New Products and Business Tools at 21st International Conference 3Health News:Update: Medicare Picks N.J. to Test Innovative Incentive System 2Health News:Expresso Fitness(R) Announces $6M Series D Funding 2Health News:Expresso Fitness(R) Announces $6M Series D Funding 3Health News:What Oklahomans Should Know About Cataract Surgery 2Health News:What Oklahomans Should Know About Cataract Surgery 3Health News:What Texans Should Know about Cataract Surgery 2Health News:What Texans Should Know about Cataract Surgery 3Health News:Antioxidants Abound in Cereals, Popcorn, Whole-Grain Snacks 2Health News:Antioxidants Abound in Cereals, Popcorn, Whole-Grain Snacks 3
    Medtronic Ophthalmics offers a comprehensive selection of corneal trephine,blades and handles. Handcrafted, sharp, uniform blade edges promote a,symetrical and vertical cut of all corneal layers....
    Medtronic Ophthalmics offers a comprehensive selection of corneal trephine,blades and handles. Handcrafted, sharp, uniform blade edges promote a,symetrical and vertical cut of all corneal layers....
    Medtronic Ophthalmics offers a comprehensive selection of corneal trephine,blades and handles. Handcrafted, sharp, uniform blade edges promote a,symetrical and vertical cut of all corneal layers....
    Medtronic Ophthalmics offers a comprehensive selection of corneal trephine,blades and handles. Handcrafted, sharp, uniform blade edges promote a,symetrical and vertical cut of all corneal layers....
    Medicine Products: